Results for 'Nurses'
The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
CDER, FDA, Nurses, biomarker, immunomodulatory
Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…
Mar 30th • 53 mins listen
The Oncology Nursing Podcast
Biosimilar Basics for Oncology Nurses and Patients
“The way I approach patient education conversations is to discuss it, address it, but not to emphasize it. I really like to focus on what the drug is. I mention if it’s a biosimilar, I explain it, I give resources if they want it, but I really try to focus on the things that they&rsquo…
Feb 1st • 30 mins listen
The Oncology Nursing Podcast
Industry Challenges Contribute to Financial Toxicity
In this third panel discussion from ONS’s Health Policy Summit in Washington DC, Alan Balch, PhD, Patient Advocate Foundation chief executive officer, Mike Ybarra, MD, FAAEM, FACEP, vice president of medical affairs for the Pharmaceutical Research Manufacturers Association, and Jeannine…
Feb 18th • 66 mins listen
The Oncology Nursing Podcast
How Washington Is Tackling High Prescription Drug Costs
Dede Sweeney, ONS’s director of government affairs, joins Chris Pirschel, ONS staff writer, to discuss Congress’s plan to address high prescription drug costs, what the current administration is doing about it, what nurses can do to help their patients, and more.
Feb 16th • 32 mins listen
The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development
ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…
Oct 16th • 38 mins listen
The Oncology Nursing Podcast
New Guidelines for Managing Immunotherapy-Related Adverse Events
ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educati…
Feb 19th • 13 mins listen
The Oncology Nursing Podcast
Breaking Down Checkpoint Inhibitors
ONS member Virginia Bayer, BSN, RN, CCRP, research nurse supervisor at MD Anderson Cancer Center, joins ONS’s Barbara Lubejko, MS, RN, to discuss checkpoint inhibitors, their impact on patient care, what oncology nurses need to know about immunotherapies, and much more.
Mar 14th • 51 mins listen
The Oncology Nursing Podcast
How CAR and Other T Cells Are Revolutionizing Cancer Treatment
ONS member Cecily Snyder, BSN, RN, OCN®, BMTCN®, transplant case manager of the blood and marrow transplantation program at Nebraska Medicine in Omaha and member of the Metro Omaha ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss T-cell therapy…
Jan 24th • 27 mins listen
The Oncology Nursing Podcast
CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation
“Just like with anything we do in oncology, a lot of education is required. Nurses and coordinators are critical to start the education and provide effective resources that are reinforced throughout the treatment,” ONS member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, F…
May 24th • 40 mins listen
The Oncology Nursing Podcast
Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon
ONS members Meghan Coleman, DNP, CRNP, and Alison McDaniel, BSN, RN, OCN®, join Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss their Evidence-Based Quality Understanding in Pathology (EQUIP) project to solve unequal access to germline and s…
Dec 24th • 46 mins listen
The Oncology Nursing Podcast
Biomarker Testing Improves Outcomes for Patients With Non-Small Cell Lung Cancer
ONS member Beth Sandy, MSN, CRNP, thoracic oncology nurse practitioner at the University of Pennsylvania Abramson Cancer Center in Philadelphia, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss key considerations for oncology nurses regarding biomarker testing for …
May 24th • 34 mins listen
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…
Mar 30th • 47 mins listen